{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:33:08Z","timestamp":1773214388683,"version":"3.50.1"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Rosacea is a persistent inflammatory dermatosis with a multifactorial etiology that significantly impairs patients\u2019 daily life and wellbeing. Vicenin-2, a natural flavonoid, has shown anti-inflammatory potential; however, its therapeutic mechanism in rosacea remains unclear. We seek to understand the potential and mechanism of Vicenin-2 in the treatment of rosacea.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Differentially expressed genes (DEGs) related to rosacea were identified from the Gene Expression Omnibus (GEO) dataset GSE65914 using GEO2R. Potential targets of Vicenin-2 were predicted via PharmMapper and SwissTargetPrediction, and overlapping targets were selected. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted using DAVID. Core targets were identified through STRING and Cytoscape, and molecular docking was performed to evaluate binding affinity.\n                      <jats:italic>In vivo<\/jats:italic>\n                      rosacea mouse models and\n                      <jats:italic>in vitro<\/jats:italic>\n                      HaCaT cell models were established to validate therapeutic effects using histological staining, immunofluorescence, immunohistochemistry, Enzyme-Linked Immunosorbent Assay (ELISA), Reverse Transcription Quantitative Polymerase Chain Reaction (RT-qPCR), and Western blotting.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Forty-three candidate targets of Vicenin-2 were identified. Enrichment analyses indicated that these targets were mainly involved in immune regulation and inflammatory responses, with the IL-17 signaling pathway as a key pathway. Molecular docking revealed strong binding between Vicenin-2 and MMP1 and MMP3. Experimental results showed that topical Vicenin-2 significantly reduced erythema and inflammatory cell infiltration in mice. Both\n                      <jats:italic>in vivo<\/jats:italic>\n                      and\n                      <jats:italic>in vitro<\/jats:italic>\n                      assays confirmed that Vicenin-2 modulates the IL-17RA\/NF-\u03baB pathway, suppressing the expression of inflammatory mediators and matrix metalloproteinases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Vicenin-2 alleviates LL-37-induced rosacea-like inflammation by regulating the IL-17RA\/NF-\u03baB pathway and exerting multi-target anti-inflammatory and immunomodulatory effects, suggesting its potential as a novel therapeutic agent for rosacea. Trial registration: not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1793115","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:45:11Z","timestamp":1773135911000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Vicenin-2 attenuates rosacea-like inflammation by inhibiting IL-17RA signaling"],"prefix":"10.3389","volume":"17","author":[{"given":"Meng","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Dermatovenereology, Affiliated Hospital of North Sichuan Medical College","place":["Nanchong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Dermatovenereology, Affiliated Hospital of North Sichuan Medical College","place":["Nanchong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenlong","family":"Shuai","sequence":"additional","affiliation":[{"name":"Department of Dermatovenereology, Affiliated Hospital of North Sichuan Medical College","place":["Nanchong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"He","sequence":"additional","affiliation":[{"name":"Department of Dermatovenereology, Affiliated Hospital of North Sichuan Medical College","place":["Nanchong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Dermatovenereology, Affiliated Hospital of North Sichuan Medical College","place":["Nanchong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowen","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Dermatovenereology, Affiliated Hospital of North Sichuan Medical College","place":["Nanchong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Dermatovenereology, Affiliated Hospital of North Sichuan Medical College","place":["Nanchong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatovenereology, Affiliated Hospital of North Sichuan Medical College","place":["Nanchong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Dermatovenereology, Affiliated Hospital of North Sichuan Medical College","place":["Nanchong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2017.01.006","article-title":"IL-17 signaling: the yin and the yang","volume":"38","author":"Amatya","year":"2017","journal-title":"Trends Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1177\/1203475419867611","article-title":"The role of IL-17 in papulopustular rosacea and future directions","volume":"23","author":"Amir","year":"2019","journal-title":"J. Cutan. Med. Surg."},{"key":"B3","doi-asserted-by":"publisher","first-page":"11292","DOI":"10.3390\/ijms262311292","article-title":"Molecular mechanisms in the etiopathology of rosacea-systematic review","volume":"26","author":"Andrusiewicz","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.molmed.2016.01.001","article-title":"IL-17 in chronic inflammation: from discovery to targeting","volume":"22","author":"Beringer","year":"2016","journal-title":"Trends Mol. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1038\/jid.2015.141","article-title":"Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of Th1\/Th17 pathways","volume":"135","author":"Buhl","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/ddg.14849","article-title":"S2k guideline: rosacea","volume":"20","author":"Clanner-Engelshofen","year":"2022","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"B7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jaad.2004.03.030","article-title":"Rosacea: I. Etiology, pathogenesis, and subtype classification","volume":"51","author":"Crawford","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/s1050-1738(01)00160-8","article-title":"Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction","volume":"12","author":"D'Armiento","year":"2002","journal-title":"Trends Cardiovasc. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7555\/JBR.38.20240107","article-title":"Therapy outcomes of IL-17 and JAK inhibitors in rosacea: a systematic review","volume":"39","author":"Dai","year":"2024","journal-title":"J. Biomed. Res."},{"key":"B10","first-page":"694","article-title":"Why is rosacea considered to be an inflammatory disorder? The primary role, clinical relevance, and therapeutic correlations of abnormal innate immune response in rosacea-prone skin","volume":"11","author":"Del","year":"2012","journal-title":"J. Drugs Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e104202","DOI":"10.15252\/embj.2019104202","article-title":"Systematic analysis of the IL-17 receptor signalosome reveals a robust regulatory feedback loop","volume":"39","author":"Draberova","year":"2020","journal-title":"EMBO. J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jphotobiol.2018.11.018","article-title":"Vicenin-2 ameliorates oxidative damage and photoaging via modulation of MAPKs and MMPs signaling in UVB radiation exposed human skin cells","volume":"190","author":"Duan","year":"2019","journal-title":"J. Photochem. Photobiol. B"},{"key":"B13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s13555-018-0249-y","article-title":"Topical ivermectin in the treatment of papulopustular rosacea: a systematic review of evidence and clinical Guideline recommendations","volume":"8","author":"Ebbelaar","year":"2018","journal-title":"Dermatol. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"111636","DOI":"10.1016\/j.intimp.2024.111636","article-title":"Oroxylin A suppress LL-37 generated rosacea-like skin inflammation through the modulation of SIRT3-SOD2-NF-\u03baB signaling pathway","volume":"129","author":"Feng","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1096\/fj.13-235440","article-title":"Unexpected low-dose toxicity of the universal solvent DMSO","volume":"28","author":"Galvao","year":"2014","journal-title":"FASEB. J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/bjd.16481","article-title":"Incidence and prevalence of rosacea: a systematic review and meta-analysis","volume":"179","author":"Gether","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"111489","DOI":"10.1016\/j.celrep.2022.111489","article-title":"IL-17-induced dimerization of IL-17RA drives the formation of the IL-17 signalosome to potentiate signaling","volume":"41","author":"Goepfert","year":"2022","journal-title":"Cell Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/jdv.70112","article-title":"The exposomal imprint on rosacea: more than skin deep","volume":"40","author":"Grafanaki","year":"2025","journal-title":"J. Eur. Acad. Dermatol. Venereol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"113340","DOI":"10.1016\/j.jphotobiol.2025.113340","article-title":"Hydroxysafflower yellow a protects against UVA- and UVB-induced skin aging by suppressing cell apoptosis and SASP via targeting JNK and p38 MAPK pathway","volume":"274","author":"Guo","year":"2025","journal-title":"J. Photochem. Photobiol. B"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/jocd.14169","article-title":"Serum IL-17 levels in patients with rosacea","volume":"21","author":"Hayran","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jamadermatol.2014.4728","article-title":"Clinical, histologic, and molecular analysis of differences between erythematotelangiectatic rosacea and telangiectatic photoaging","volume":"151","author":"Helfrich","year":"2015","journal-title":"JAMA Dermatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"113117","DOI":"10.1016\/j.jphotobiol.2025.113117","article-title":"Vicenin-2 reduces inflammation and apoptosis to relieve skin photoaging via suppressing GSK3\u03b2","volume":"264","author":"Hu","year":"2025","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s10787-025-01639-8","article-title":"Casticin reduces rosacea-related inflammation by inhibiting mast cell activation via Mas-related G protein-coupled receptor X2","volume":"33","author":"Jia","year":"2025","journal-title":"Inflammopharmacology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e142067","DOI":"10.1172\/jci.insight.142067","article-title":"Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin","volume":"5","author":"Jiang","year":"2020","journal-title":"JCI Insight"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00011-015-0886-x","article-title":"Anti-inflammatory effects of vicenin-2 and scolymoside in vitro and in vivo","volume":"64","author":"Kang","year":"2015","journal-title":"Inflamm. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"570","DOI":"10.2174\/0929866522666150520145554","article-title":"An overview of Interleukin-17A and Interleukin-17 receptor A structure, interaction and signaling. Protein pept","volume":"22","author":"Krstic","year":"2015","journal-title":"Lett"},{"key":"B27","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/bjd.19172","article-title":"An exploratory, open-label, investigator-initiated study of interleukin-17 blockade in patients with moderate-to-severe papulopustular rosacea","volume":"183","author":"Kumar","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.vetimm.2014.04.001","article-title":"Validation of a commercial canine assay kit to measure pinniped cytokines","volume":"160","author":"Levin","year":"2014","journal-title":"Vet. Immunol. Immunopathol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/s41590-019-0514-y","article-title":"IL-17 receptor-based signaling and implications for disease","volume":"20","author":"Li","year":"2019","journal-title":"Nat. Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.intimp.2018.12.031","article-title":"Tranexamic acid ameliorates rosacea symptoms through regulating immune response and angiogenesis","volume":"67","author":"Li","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1021\/np100937e","article-title":"Vicenin-2, a potential anti-inflammatory constituent of Urtica circularis","volume":"74","author":"Marrassini","year":"2011","journal-title":"J. Nat. Prod."},{"key":"B32","doi-asserted-by":"publisher","first-page":"122675","DOI":"10.1016\/j.lfs.2024.122675","article-title":"Quercetin attenuates inflammation in rosacea by directly targeting p65 and ICAM-1","volume":"347","author":"Meng","year":"2024","journal-title":"Life Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3390\/ph18091273","article-title":"A comprehensive review of Azelaic acid pharmacological properties, clinical applications, and innovative topical formulations","volume":"18","author":"Petrovici","year":"2025","journal-title":"Pharmaceuticals"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1093\/ced\/llaf308","article-title":"Extracellular matrix alterations in inflammatory skin diseases: emerging biomarkers and clinical implications","volume":"50","author":"Port","year":"2025","journal-title":"Clin. Exp. Dermatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1007\/s10753-025-02278-5","article-title":"DNAJB2 attenuates rosacea skin inflammation and angiogenesis by inhibiting the endoplasmic reticulum stress-mediated TLR2\/Myd88\/NF-\u03baB pathway","volume":"48","author":"Qing","year":"2025","journal-title":"Inflammation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e1361574","DOI":"10.1080\/19381980.2017.1361574","article-title":"Rosacea: epidemiology, pathogenesis, and treatment","volume":"9","author":"Rainer","year":"2017","journal-title":"Dermatoendocrinol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"611","DOI":"10.4103\/ijdvl.IJDVL_769_19","article-title":"Rosacea in skin of color: a comprehensive review","volume":"86","author":"Sarkar","year":"2020","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1111\/jdv.14437","article-title":"Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea","volume":"31","author":"Schaller","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/jidsymp.2011.6","article-title":"Neurovascular and neuroimmune aspects in the pathophysiology of rosacea","volume":"15","author":"Schwab","year":"2011","journal-title":"J. Investig. Dermatol Symp. Proc."},{"key":"B40","doi-asserted-by":"publisher","first-page":"118874","DOI":"10.1016\/j.biopha.2025.118874","article-title":"Protective effect of a novel metal-phenolic network composite against ultraviolet-induced skin damage by modulating MAPK\/AP-1\/NF-\u03baB signaling pathways and attenuating oxidative stress in human keratinocytes","volume":"193","author":"Shin","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.jaad.2020.01.077","article-title":"Standard management options for rosacea: the 2019 update by the national rosacea society expert committee","volume":"82","author":"Thiboutot","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.tcb.2012.08.001","article-title":"The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation","volume":"22","author":"Tornatore","year":"2012","journal-title":"Trends Cell Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1038\/sj.bjc.6604357","article-title":"Vascular tube formation on matrix metalloproteinase-1-damaged collagen","volume":"98","author":"Varani","year":"2008","journal-title":"Br. J. Cancer."},{"key":"B44","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/17512433.2025.2550727","article-title":"Treatment management for rosacea: current pharmacological and non-pharmacological options","volume":"18","author":"Volk","year":"2025","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"120492","DOI":"10.1016\/j.jep.2025.120492","article-title":"Therapeutic effects of the n-butanol extract of Potentilla freyniana bornm. in hepatocellular carcinoma cells","volume":"354","author":"Wang","year":"2026","journal-title":"J. Ethnopharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e21457","DOI":"10.1096\/fj.202002393RR","article-title":"Fish NF-\u03baB couples TCR and IL-17 signals to regulate ancestral T-cell immune response against bacterial infection","volume":"35","author":"Wei","year":"2021","journal-title":"FASEB. J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nat. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/jid.2010.351","article-title":"TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes","volume":"131","author":"Yamasaki","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1367994","DOI":"10.3389\/fimmu.2024.1367994","article-title":"Signaling pathways and targeted therapy for rosacea","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3760\/cma.j.issn.1009-2587.2016.01.011","article-title":"Effect of rapamycin on the migration of human epidermal cell line HaCaT and its possible molecular mechanism","volume":"32","author":"Zhang","year":"2016","journal-title":"Zhonghua Shao Shang Za Zhi"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e70096","DOI":"10.1096\/fj.202400006R","article-title":"IL-17A-neutralizing antibody ameliorates inflammation and fibrosis in rosacea by antagonizing the CXCL5\/CXCR2 axis","volume":"38","author":"Zhang","year":"2024","journal-title":"FASEB. J."},{"key":"B52","doi-asserted-by":"publisher","first-page":"116306","DOI":"10.1016\/j.jep.2023.116306","article-title":"Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula","volume":"309","author":"Zhao","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1092473","DOI":"10.3389\/fphar.2023.1092473","article-title":"EGCG identified as an autophagy inducer for rosacea therapy","volume":"14","author":"Zhou","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s40538-025-00856-1","article-title":"Synergistic anti-photoaging and anti-inflammatory effects of Eucommia ulmoides, Styphnolobium japonicum, and Portulaca oleracea extracts via TGF-\u03b2\/Smad\/IL-17 pathway","volume":"12","author":"Zhu","year":"2025","journal-title":"Chem. Biol. Technol. Agric."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1793115\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:45:13Z","timestamp":1773135913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1793115\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":54,"alternative-id":["10.3389\/fphar.2026.1793115"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1793115","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"article-number":"1793115"}}